Industry & Business

Medical manufacturer West Pharmaceutical Services, Inc. announced on Tuesday, November 29, the completion of a 60,000 square foot expansion at its contract manufacturing facility near Mulhuddart, County Dublin. The expansion was initiated in response to customer demand for medical device manufacturing, especially in the area of diabetes.

West Pharmaceutical Services, Inc. manufactures packaging components and delivery systems for injectable drugs. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West’s 2015 sales of $1.4 billion reflect the daily use of approximately 110 million of its components and devices.

West also announced that its contract manufacturing business formerly known as The Tech Group will now align with the West brand and do business as “West.” West anticipates 100 new jobs will be added to the business over the next five years as a result of the expansion.

Along with the expansion of its Dublin facility, West is also growing its proprietary product business in Waterford, Ireland. The Company previously announced the construction of a centre of excellence for its proprietary elastomeric sheeting and injectable component product lines. The new plant is expected to begin full commercial operations in 2018.

Martin Shanahan, CEO, IDA Ireland said, “Ireland has seen hundreds of millions invested in recent years in the development and manufacturing of new injectable drugs for diabetes, cardiovascular disease, autoimmune disease and cancer. The patients who will benefit from these exciting new drugs will also benefit from West’s innovation in drug delivery devices.”